17-Beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology

Oncology

Volumn 59, Issue SUPPL. 1, 2000, Pages 5-12

  Sasano, Hironobu ^a   Suzuki, Takashi ^a   Takeyama, Junji ^a   Utsunomiya, Hiroki ^a   Ito, Kiyoshi ^a   Ariga, Naohiro ^a   Moriya, Takuya ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

17 Hydroxysteroid dehydrogenase; Breast; Endometrium; Estrogen; Intracrinology

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; ISOENZYME; TESTOSTERONE 17BETA DEHYDROGENASE;

AGE; BREAST CARCINOMA; BREAST HYPERPLASIA; CELL STIMULATION; CONFERENCE PAPER; ENDOMETRIUM CARCINOMA; ENZYME SPECIFICITY; ESTROGEN SYNTHESIS; HISTOPATHOLOGY; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; HUMAN; INVASIVE CARCINOMA; MENSTRUAL CYCLE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033661942     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055281     Document Type: Conference Paper

References (42)

1. Cancer of the breast: The past decade
2. Aromatase activity in breast tissue
3. Aromatization of androstenedione by cultured human fibroblasts
4. Aromatization of androgens by muscle and adipose tissue in vivo
5. Aromatase in human bone tissue
6. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
7. Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue
8. Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis
9. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer
10. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women
11. Serum sex hormone levels after menopause and subsequent breast cancer
12. Studies of oestrogen metabolism in postmenopausal women with cancer
13. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer
14. Origin of estrogen in a post-menopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia
15. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer
16. Significance of aromatase activity in human breast cancer
17. The conversion of androstenedione to estrone, estradiol and testosterone in breast tissue
18. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation
19. Aromatase cytochrome P450 gene expression in endometrial carcinoma
20. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies
21. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies
22. DHEA and peripheral androgen and estrogen formation: Intracrinology
23. Characterization of cDNAs for human estradiol 17β-HSD dehydrogenase and assignment of the gene to chromosome 17: Evidence for two mRNA species with distinct 5'-termini in human placenta
24. Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isozymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression
25. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity
26. 17β-hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium
27. 17β-hydroxysteroid and 20α-hydroxysteroid dehydrogenase activities of human placental microsomes: Kinetic evidence for two enzymes differing in substrate specificity
28. Risk factors for breast cancer in women with proliferative breast disease
29. Atypical hyperplastic lesions of the female breast; a long-term follow-up study
30. A prospective study of benign breast disease and the risk of breast cancer
31. Cycline D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast
32. Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines
33. 17β-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: A correlation to clinicopathological parameters
34. Human 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle
35. Characterization and comparison of receptors for 17β-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma
36. 17β-Hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progentin regulation of gene expression in human endometrium
37. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
38. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women
39. Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen
40. The biologic significance of cytologic atypia in progesten-treated endometrial hyperplasia
41. Inhibitory effects of medroxyprogesterone acetate on mouse endometrial carcinogenesis
42. Effects of hormone therapy on the endometrium